| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |